nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19
|
Perini, Paolo |
|
|
395 |
10236 |
p. 1546 |
artikel |
2 |
Adjuvant nivolumab plus ipilimumab for resected stage IV melanoma
|
Sullivan, Ryan Joseph |
|
|
395 |
10236 |
p. 1524-1525 |
artikel |
3 |
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial
|
Zimmer, Lisa |
|
|
395 |
10236 |
p. 1558-1568 |
artikel |
4 |
Artificial intelligence and the future of global health
|
Schwalbe, Nina |
|
|
395 |
10236 |
p. 1579-1586 |
artikel |
5 |
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
|
Galsky, Matthew D |
|
|
395 |
10236 |
p. 1547-1557 |
artikel |
6 |
Calling for a COVID-19 One Health Research Coalition
|
Amuasi, John H |
|
|
395 |
10236 |
p. 1543-1544 |
artikel |
7 |
Computer vision's potential to improve health care
|
Milstein, Arnold |
|
|
395 |
10236 |
p. 1537 |
artikel |
8 |
Considering BCG vaccination to reduce the impact of COVID-19
|
Curtis, Nigel |
|
|
395 |
10236 |
p. 1545-1546 |
artikel |
9 |
COVID-19-associated nephritis: early warning for disease severity and complications?
|
Gross, Oliver |
|
|
395 |
10236 |
p. e87-e88 |
artikel |
10 |
Full neurological recovery 6 h after cardiac arrest due to accidental hypothermia
|
Riera, Jordi |
|
|
395 |
10236 |
p. e89 |
artikel |
11 |
Immune checkpoint inhibition in urothelial carcinoma
|
Szabados, Bernadett |
|
|
395 |
10236 |
p. 1522-1523 |
artikel |
12 |
Increasing the visibility of older women in clinical research
|
Rochon, Paula A |
|
|
395 |
10236 |
p. 1530-1532 |
artikel |
13 |
Institutional, not home-based, isolation could contain the COVID-19 outbreak
|
Dickens, Borame L |
|
|
395 |
10236 |
p. 1541-1542 |
artikel |
14 |
In the aftermath: the legacy of measles in Samoa
|
Thornton, Jacqui |
|
|
395 |
10236 |
p. 1535-1536 |
artikel |
15 |
Is the HScore useful in COVID-19?
|
Leverenz, David L |
|
|
395 |
10236 |
p. e83 |
artikel |
16 |
Martin Khor Kok Peng
|
Watts, Geoff |
|
|
395 |
10236 |
p. 1540 |
artikel |
17 |
Obesity could shift severe COVID-19 disease to younger ages
|
Kass, David A |
|
|
395 |
10236 |
p. 1544-1545 |
artikel |
18 |
Offline: Don't let COVID-19 divert us completely
|
Horton, Richard |
|
|
395 |
10236 |
p. 1534 |
artikel |
19 |
Preventing major outbreaks of COVID-19 in jails
|
Okano, Justin T |
|
|
395 |
10236 |
p. 1542-1543 |
artikel |
20 |
Remdesivir for COVID-19: challenges of underpowered studies
|
Norrie, John David |
|
|
395 |
10236 |
p. 1525-1527 |
artikel |
21 |
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|
Wang, Yeming |
|
|
395 |
10236 |
p. 1569-1578 |
artikel |
22 |
Reviving the US CDC
|
The Lancet, |
|
|
395 |
10236 |
p. 1521 |
artikel |
23 |
SARS-CoV-2 and influenza virus co-infection
|
Cuadrado-Payán, Elena |
|
|
395 |
10236 |
p. e84 |
artikel |
24 |
The arrival of SARS-CoV-2 in Venezuela
|
Paniz-Mondolfi, Alberto E |
|
|
395 |
10236 |
p. e85-e86 |
artikel |
25 |
The COVID-19 response for vulnerable people in places affected by conflict and humanitarian crises
|
Nott, David |
|
|
395 |
10236 |
p. 1532-1533 |
artikel |
26 |
Trial and error
|
Ofri, Danielle |
|
|
395 |
10236 |
p. 1538-1539 |
artikel |
27 |
What policy makers need to know about COVID-19 protective immunity
|
Altmann, Daniel M |
|
|
395 |
10236 |
p. 1527-1529 |
artikel |